MedTrace Logo

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

NCT02689401 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

This research study is evaluating a new imaging method using MRI (magnetic resonance imaging) to evaluate lymph nodes for evidence of tumor spread from esophageal cancer. This MRI study involves an intravenous contrast called Ferumoxytol (FerahemeTM).

Conditions

  • Esophageal Cancer

Interventions

DRUG

Ferumoxytol

DEVICE

MRI 3T scanner

Sponsors & Collaborators

Principal Investigators

  • Yolonda Colson, MD PhD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689401 on ClinicalTrials.gov